PUBLICATION
p53 activation by knockdown technologies
- Authors
- Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A., and Ekker, S.C.
- ID
- ZDB-PUB-070614-15
- Date
- 2007
- Source
- PLoS Genetics 3(5): e78 (Journal)
- Registered Authors
- Ekker, Stephen C., Farber, Steven, Larson, Jon D., Nasevicius, Aidas
- Keywords
- Embryos, Apoptosis, Cell death, Zebrafish, Phenotypes, Small interfering RNAs, Bright field microscopy, Microarrays
- MeSH Terms
-
- Protein Isoforms/genetics
- Protein Isoforms/metabolism
- Transcriptional Activation*
- Neurons/cytology
- Neurons/drug effects
- Neurons/metabolism
- Time Factors
- Gene Expression Regulation, Developmental/drug effects
- Artifacts
- Animals
- Morpholinos
- Substrate Specificity
- Embryonic Development/drug effects
- Embryonic Development/genetics
- Morpholines/pharmacology
- Phenotype
- Tumor Suppressor Protein p53/chemistry
- Tumor Suppressor Protein p53/genetics*
- Tumor Suppressor Protein p53/metabolism
- Genetic Techniques*
- Zebrafish/embryology
- Zebrafish/genetics*
- Apoptosis/drug effects
- Embryo, Nonmammalian/cytology
- Embryo, Nonmammalian/drug effects
- Embryo, Nonmammalian/embryology
- Embryo, Nonmammalian/metabolism
- Sensitivity and Specificity
- Cyclin-Dependent Kinase Inhibitor p21/genetics
- Cyclin-Dependent Kinase Inhibitor p21/metabolism
- PubMed
- 17530925 Full text @ PLoS Genet.
Citation
Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A., and Ekker, S.C. (2007) p53 activation by knockdown technologies. PLoS Genetics. 3(5):e78.
Abstract
Morpholino phosphorodiamidate antisense oligonucleotides (MOs) and short interfering RNAs (siRNAs) are commonly used platforms to study gene function by sequence-specific knockdown. Both technologies, however, can elicit undesirable off-target effects. We have used several model genes to study these effects in detail in the zebrafish, Danio rerio. Using the zebrafish embryo as a template, correct and mistargeting effects are readily discernible through direct comparison of MO-injected animals with well-studied mutants. We show here indistinguishable off-targeting effects for both maternal and zygotic mRNAs and for both translational and splice-site targeting MOs. The major off-targeting effect is mediated through p53 activation, as detected through the transferase-mediated dUTP nick end labeling assay, acridine orange, and p21 transcriptional activation assays. Concurrent knockdown of p53 specifically ameliorates the cell death induced by MO off-targeting. Importantly, reversal of p53-dependent cell death by p53 knockdown does not affect specific loss of gene function, such as the cell death caused by loss of function of chordin. Interestingly, quantitative reverse-transcriptase PCR, microarrays and whole-mount in situ hybridization assays show that MO off-targeting effects are accompanied by diagnostic transcription of an N-terminal truncated p53 isoform that uses a recently recognized internal p53 promoter. We show here that MO off-targeting results in induction of a p53-dependent cell death pathway. p53 activation has also recently been shown to be an unspecified off-target effect of siRNAs. Both commonly used knockdown technologies can thus induce secondary but sequence-specific p53 activation. p53 inhibition could potentially be applicable to other systems to suppress off-target effects caused by other knockdown technologies.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping